PORTLAND, OR, Nov. 04, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global peptide therapeutics market was valued at US$33.3 billion in 2021 and is projected to reach US$64.3 billion by 2031, at a CAGR of 6.8% from 2022 to 2031. The report provides a detailed analysis of the top investment bags, top winning strategies, drivers and opportunities, market size & estimates, competitive landscape, and evolving market trends. The market study is a helpful source of information for frontrunners, newcomers, investors and shareholders to develop strategies for the future and to strengthen their position in the market.
Download the free sample report (309-page PDF with insights, charts, tables, figures): https://www.alliedmarketresearch.com/request-sample/11591
Report coverage and details:
| report coverage | details |
| forecast period | 2022-2031 |
| Market size in 2031 | $64.3 billion |
| CAGR | 6.8% |
| Number of pages in the report | 309 |
| Covered Segments | Application, route of administration, distribution channel and region. |
| driver | Increase in the prevalence of chronic diseases |
| Growing patient awareness of advances in peptide therapy | |
| occasions | High growth potential for the oral peptide therapeutics market |
| limitations | Low bioavailability of peptides along with the high costs associated with drug development |
Covid-19 Scenario-
- The strong government support for the use of peptides in the manufacture of the Covid-19 vaccines creates a number of opportunities for peptides…
